Besides, exogenous HA was reported to competitively bound to CD44 with endogenous HA, which leads to the suppression of PI3-kinase/Akt cell survival pathway and consequently to inhibition of anchorage-independent growth in culture and tumor growth in vivo [66], indicating hydrogel made from HA has great potential in tumor treatment. The gene discussed is CD44; the disease is neoplasm.